학술논문
Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE
Document Type
Article
Author
Mamounas, E.P.; Untch, M.; Mano, M.S.; Huang, C.-S.; Geyer Jr, C.E.; von Minckwitz, G.; Wolmark, N.; Pivot, X.; Kuemmel, S.; DiGiovanna, M.P.; Kaufman, B.; Kunz, G.; Conlin, A.K.; Alcedo, J.C.; Kuehn, T.; Wapnir, I.; Fontana, A.; Hackmann, J.; Polikoff, J.; Saghatchian, M.; Brufsky, A.; Yang, Y.; Zimovjanova, M.; Boulet, T.; Liu, H.; Tesarowski, D.; Lam, L.H.; Song, C.; Smitt, M.; Loibl, S.
Source
In Annals of Oncology August 2021 32(8):1005-1014
Subject
Language
ISSN
0923-7534